Palantir Technologies Inc. closed at $127.99 on Friday, down 2.36%, as the market continues to grapple with the company's lofty valuation and emerging risks surrounding its government contracts. Early Monday trading showed the stock hovering near the same level, with little change in sentiment.
The data analytics firm is set to report its second-quarter results, with revenue guidance between $1.797 billion and $1.801 billion. While the company has posted impressive growth driven by U.S. AI demand, its price-to-earnings ratio of approximately 144 leaves little margin for error, according to analysts.
Growth Story vs. Valuation Concerns
Palantir's first-quarter revenue reached $1.633 billion, an 85% year-over-year increase, with U.S. commercial revenue surging 133%. CEO Alex Karp highlighted a Rule of 40 score of 145%, far exceeding the typical software benchmark of 40%. However, the stock's high multiple means that any disappointment could trigger significant downside.
Bears point to governance issues and the company's heavy reliance on public sector contracts. A June 9 SEC filing revealed that shareholders voted down proposals related to due diligence, human-rights review, and political spending. Barron's reported that 56% of outside shareholders supported the human-rights review, excluding insider votes.
Contract Risks Intensify
Reuters reported that the UK government is reviewing Palantir's £330 million contract with the National Health Service, with a potential termination in 2027. This adds to existing concerns about the company's dependence on government business. U.S. government revenue for the first quarter was $687 million, up 84% year-over-year.
Analyst opinions remain mixed. MarketBeat tracks 31 analysts with a 12-month average price target of $192.76, ranging from $90 to $255. Bulls emphasize the AI Platform's potential and strong federal and commercial sales, while bears warn that growth expectations are already priced in and highlight contract and governance risks.
Palantir's stock continues to trade at a significant premium, reflecting both optimism and vulnerability. The upcoming Q2 results will be closely watched for revenue in the guided range, sustained U.S. commercial demand, and stable margins amid ongoing contract headlines and political scrutiny.
